GreenLight SPAC Presentation Deck

Our cell-free engine has overcome development and commercialization barriers for RNA We remove hurdles to implementing and scaling RNA for human, plant, and animal health Identify Bioinformatics MOLE Boh 11000016 10000 Develop and optimize Massive parallel trials High-throughput automation enables trialing of 1,000s of distinct RNA sequences for human health and food security Tools such as machine learning and proprietary algorithms identify best gene target candidates to protect food crops, design advanced medicines and vaccines for human and animal health Investor Presentation | © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential. Rochester facility dsRNA installed capacity at 500 kg per year with ready expansion to 1,000 kg Scale Commercialize at competitive prices Proprietary cell-free system enables scale up of RNA manufacturing, effectively, expediently and at lower costs 11

View entire presentation